We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+12.77%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$52.5B
AUM Growth
+$13.1B
(+33%)
Cap. Flow
+$7.72B
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
17.31%
Holding
2,462
New
319
Increased
921
Reduced
776
Closed
312
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$436M |
| 3 |
Apple
AAPL
|
+$415M |
| 4 |
Microsoft
MSFT
|
+$396M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booz Allen Hamilton
BAH
|
+$120M |
| 2 |
Walt Disney
DIS
|
+$115M |
| 3 |
Wingstop
WING
|
+$89.6M |
| 4 |
Cisco
CSCO
|
+$88.1M |
| 5 |
Amphenol
APH
|
+$84.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Healthcare | 10.33% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Industrials | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
C4 Therapeutics
CCCC
$376M
| $112K | ﹤0.01% |
78,487
-7,136
| -8% | -$10.4K |
|
2002
Black Diamond Therapeutics
BDTX
$101M
| $103K | ﹤0.01% |
+41,577
| New | +$80.1K |
|
2003
Latham Group
SWIM
$646M
| $95.7K | ﹤0.01% |
+15,002
| New | +$87.2K |
|
2004
Radiant Logistics
RLGT
$416M
| $92.6K | ﹤0.01% |
15,223
-12,307
| -45% | -$73.6K |
|
2005
Health Catalyst
HCAT
$154M
| $91.4K | ﹤0.01% |
24,247
-42,821
| -64% | -$168K |
|
|
SFIX
2006
Stitch Fix
SFIX
$478M
| $90.5K | ﹤0.01% |
24,470
-5,816
| -19% | -$21.8K |
|
|
SELF
2007
Global Self Storage
SELF
$57.7M
| $87.5K | ﹤0.01% |
16,377
-2,001
| -11% | -$10.7K |
|
|
BTM
2008
DELISTED
Bitcoin Depot
BTM
| $84.1K | ﹤0.01% |
+2,369
| New | +$50.3K |
|
2009
Kaltura
KLTR
$211M
| $83.3K | ﹤0.01% |
41,461
+4,948
| +14% | +$10.3K |
|
2010
Novavax
NVAX
$1.23B
| $81K | ﹤0.01% |
+12,850
| New | +$85.1K |
|
2011
Blend Labs
BLND
$409M
| $80.4K | ﹤0.01% |
24,359
-6,122
| -20% | -$20.7K |
|
2012
Occidental Petroleum
OXY
$57B
| $79.8K | ﹤0.01% |
1,899
-6,806
| -78% | -$284K |
|
2013
RPC Inc
RES
$1.24B
| $78.8K | ﹤0.01% |
+16,668
| New | +$80.3K |
|
2014
Nuvation Bio
NUVB
$2.24B
| $75.3K | ﹤0.01% |
+38,613
| New | +$80.4K |
|
2015
Fastly Inc
FSLY
$3.17B
| $73.7K | ﹤0.01% |
10,444
-13,613
| -57% | -$91.3K |
|
|
CIO
2016
DELISTED
City Office REIT
CIO
| $72.3K | ﹤0.01% |
13,547
-81,987
| -86% | -$411K |
|
2017
GoodRx Holdings
GDRX
$1B
| $72.3K | ﹤0.01% |
14,515
-23,768
| -62% | -$103K |
|
2018
TETRA Technologies
TTI
$1.23B
| $68K | ﹤0.01% |
+20,246
| New | +$58.9K |
|
2019
Abeona Therapeutics
ABEO
$345M
| $67K | ﹤0.01% |
+11,794
| New | +$67.1K |
|
2020
OraSure Technologies
OSUR
$273M
| $64.9K | ﹤0.01% |
21,634
-30,562
| -59% | -$88.2K |
|
2021
PUT
SPDR Gold Trust
GLD
$131B
| $61K | ﹤0.01% |
+200
| New | +$60.6K |
|
|
MAPS
2022
DELISTED
WM TECHNOLOGY INC A
MAPS
| $48.5K | ﹤0.01% |
54,183
+2,737
| +5% | +$2.95K |
|
2023
Sundial Growers
SNDL
$325M
| $45.7K | ﹤0.01% |
37,800
| – | – |
|
2024
Harte-Hanks
HHS
$17.7M
| $44K | ﹤0.01% |
11,048
-20,550
| -65% | -$92K |
|
|
PARA
2025
DELISTED
Paramount Global Class B
PARA
| $43.3K | ﹤0.01% |
3,356
| – | – |
|
Similar funds
Man Group's Q2 2025 Portfolio in Review
As of Q2 2025, Man Group held 2,462 positions worth $52.5B, up 33% from $39.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group deployed $7.72B of net new capital in Q2 2025, opening 319 new positions and adding to 921 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Booz Allen Hamilton, an estimated $120M trimmed.
- Man Group's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
- Man Group added most to NVIDIA in Q2 2025, an estimated $436M increase.
- Man Group's biggest Q2 2025 reduction was Booz Allen Hamilton, cutting an estimated $120M.
- Man Group fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $81.9M.
- Man Group's ten largest holdings make up 17% of its $52.5B portfolio in Q2 2025.
- Man Group opened 319 new positions and closed 312 in Q2 2025.
- Man Group's portfolio value rose 33% quarter-over-quarter to $52.5B.
Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.